Prestige Consumer Healthcare Inc at William Blair Growth Stock Conference Transcript
Good afternoon, everybody. My name is Jon Andersen. I'm the analyst at William Blair that covers the consumer product sector. I want to welcome you to our Growth Stock Conference, and more specific, the presentation today by Prestige Consumer Healthcare.
We're pleased to have Chief Executive Officer, Ron Lombardi; Chief Financial Officer, Christine Sacco; and VP of Investor Relations and Treasury, Phil Terpolilli, here with us today. Prestige is a leading marketer of over-the-counter consumer healthcare products. The company has a diversified portfolio of market-leading brands in various categories, including Clear Eyes in eye care, Compound W in skin care, Dramamine in GI, and Monistat in women's health.
Prestige has a great long-term track record of delivering dependable organic sales growth while maintaining industry-leading margins and free cash flow and it has had success augmenting internal growth with acquisitions -- disciplined acquisitions, Ron would say, over time.
Before handing it over to management, I have a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |